IRONWOOD PHARMACEUTICALS, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $19.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2025-03-31
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-12-31 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-06-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-03-31 was $19.00K, a 97.40% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was $19.00K, a 89.56% decline from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2022 was $182.00K.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2021 was -$1.18M.
- IRONWOOD PHARMACEUTICALS, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2020 was -$6.13M, a 302.75% decline from fiscal 2019.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $19.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $19.00K 10-Q · filed 2024-11-07 | $1.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $19.00K 10-Q · filed 2024-08-08 | $1.00K derived: sum of 3 quarters · filed 2025-03-31 | $152.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-09 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $152.00K derived: sum of 3 quarters · filed 2025-03-31 | -$529.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $133.00K derived: sum of 2 quarters · filed 2025-03-31 | -$548.00K derived: sum of 3 quarters · filed 2025-03-31 | $182.00K 10-K · filed 2025-03-31 |
| 2022-09-30 | $151.00K 10-Q · filed 2023-11-09 | -$530.00K derived: sum of 2 quarters · filed 2023-11-09 | $200.00K 10-Q · filed 2023-11-09 | -$2.37M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | -$681.00K 10-Q · filed 2023-08-09 | $49.00K 10-Q · filed 2023-08-09 | -$2.52M derived: sum of 3 quarters · filed 2024-02-16 | -$353.00K derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $730.00K 10-Q · filed 2023-05-04 | -$1.84M derived: sum of 2 quarters · filed 2024-02-16 | $328.00K derived: sum of 3 quarters · filed 2024-02-16 | -$2.84M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$402.00K derived: sum of 2 quarters · filed 2024-02-16 | -$3.57M derived: sum of 3 quarters · filed 2024-02-16 | -$1.18M 10-K · filed 2024-02-16 |
| 2021-09-30 | $2.16M 10-Q · filed 2022-11-03 | -$1.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.39M 10-Q · filed 2022-11-03 | $1.81M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$3.17M 10-Q · filed 2022-08-04 | -$776.00K 10-Q · filed 2022-08-04 | -$356.00K derived: sum of 3 quarters · filed 2023-02-16 | -$2.97M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $2.39M 10-Q · filed 2022-05-05 | $2.81M derived: sum of 2 quarters · filed 2023-02-16 | $194.00K derived: sum of 3 quarters · filed 2023-02-16 | -$273.00K derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$2.20M derived: sum of 2 quarters · filed 2023-02-16 | -$2.66M derived: sum of 3 quarters · filed 2023-02-16 | -$6.13M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$2.62M 10-Q · filed 2021-11-04 | -$3.08M derived: sum of 2 quarters · filed 2021-11-04 | -$6.55M 10-Q · filed 2021-11-04 | -$2.03M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$467.00K 10-Q · filed 2021-08-05 | -$3.93M 10-Q · filed 2021-08-05 | $584.00K derived: sum of 3 quarters · filed 2022-02-18 | -$4.18M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$3.47M 10-Q · filed 2021-05-06 | $1.05M derived: sum of 2 quarters · filed 2022-02-18 | -$3.71M derived: sum of 3 quarters · filed 2022-02-18 | -$4.39M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$249.00K derived: sum of 2 quarters · filed 2022-02-18 | -$921.00K derived: sum of 3 quarters · filed 2022-02-18 | $3.02M 10-K · filed 2022-02-18 |
| 2019-09-30 | -$4.77M 10-Q · filed 2020-11-05 | -$5.44M derived: sum of 2 quarters · filed 2020-11-05 | -$1.49M 10-Q · filed 2020-11-05 | -$14.23M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | -$672.00K 10-Q · filed 2020-08-06 | $3.27M 10-Q · filed 2020-08-06 | -$9.47M derived: sum of 3 quarters · filed 2021-02-17 | -$5.98M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $3.94M 10-Q · filed 2020-05-06 | -$8.79M derived: sum of 2 quarters · filed 2021-02-17 | -$5.31M derived: sum of 3 quarters · filed 2021-02-17 | -$6.12M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | -$12.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$9.25M derived: sum of 2 quarters · filed 2021-02-17 | -$10.06M derived: sum of 3 quarters · filed 2021-02-17 | -$8.74M 10-K · filed 2021-02-17 |
| 2018-09-30 | $3.49M 10-Q · filed 2019-10-31 | $2.68M derived: sum of 2 quarters · filed 2019-10-31 | $4.00M 10-Q · filed 2019-10-31 | $1.90M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$809.00K 10-Q · filed 2019-07-30 | $507.00K 10-Q · filed 2019-07-30 | -$1.59M derived: sum of 3 quarters · filed 2020-02-13 | -$5.92M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $1.32M 10-Q · filed 2019-05-02 | -$777.00K derived: sum of 2 quarters · filed 2020-02-13 | -$5.11M derived: sum of 3 quarters · filed 2020-02-13 | $231.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$6.42M derived: sum of 2 quarters · filed 2020-02-13 | -$1.08M derived: sum of 3 quarters · filed 2020-02-13 | -$3.28M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$4.33M 10-Q · filed 2018-11-06 | $1.01M derived: sum of 2 quarters · filed 2018-11-06 | -$1.19M 10-Q · filed 2018-11-06 | $912.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $5.34M 10-Q · filed 2018-08-06 | $3.14M 10-Q · filed 2018-08-06 | $5.24M derived: sum of 3 quarters · filed 2019-02-25 | $9.78M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$2.20M 10-Q · filed 2018-05-04 | -$96.00K derived: sum of 2 quarters · filed 2019-02-25 | $4.45M derived: sum of 3 quarters · filed 2019-02-25 | $7.59M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $6.64M derived: sum of 2 quarters · filed 2019-02-25 | $9.79M derived: sum of 3 quarters · filed 2019-02-25 | $8.15M 10-K · filed 2019-02-25 |
| 2016-09-30 | $4.54M 10-Q · filed 2017-11-02 | $7.69M derived: sum of 2 quarters · filed 2017-11-02 | $6.04M 10-Q · filed 2017-11-02 | $7.66M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $3.15M 10-Q · filed 2017-08-03 | $1.50M 10-Q · filed 2017-08-03 | $3.12M derived: sum of 3 quarters · filed 2018-02-22 | -$8.22M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | -$1.64M 10-Q · filed 2017-05-08 | -$23.00K derived: sum of 2 quarters · filed 2018-02-22 | -$11.36M derived: sum of 3 quarters · filed 2018-02-22 | -$11.57M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$9.72M derived: sum of 2 quarters · filed 2018-02-22 | -$9.93M derived: sum of 3 quarters · filed 2018-02-22 | -$9.93M 10-K · filed 2018-02-22 |
| 2015-09-30 | -$11.34M 10-Q · filed 2016-11-07 | -$11.55M derived: sum of 2 quarters · filed 2016-11-07 | -$11.55M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$208.00K 10-Q · filed 2016-08-08 | -$208.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |